BRIEF published on 05/14/2024 at 23:35, 1 year 10 months ago Limestone Boat Company Reports Additional Default and Provides Manufacturing Update Limestone Boat Company Financial Restructuring Default Notice Manufacturing Update Boat Production
BRIEF published on 05/14/2024 at 23:30, 1 year 10 months ago Klondike Gold Announces $850,000 Private Placement Private Placement TSX Venture Exchange Klondike Gold Corp Securities Issuance Exploration Funding
BRIEF published on 05/14/2024 at 22:55, 1 year 10 months ago Western Alaska Minerals Completes Final Tranche of Private Placement Private Placement Investment Corporate Finance Exploration Funding Securities Law
BRIEF published on 05/14/2024 at 22:40, 1 year 10 months ago Orlando Credit Union Receives 2023 Top Community Credit Union Award for North Florida Economic Development Orlando Credit Union 2023 Award Small Business Lending North Florida
BRIEF published on 05/14/2024 at 22:40, 1 year 10 months ago First 5 Network Challenges California's Proposed State Budget Cuts California Budget Cuts Child Services First 5 Network Medi-Cal Eligibility Early Childhood Education
BRIEF published on 05/14/2024 at 22:26, 1 year 10 months ago Bausch Health Announces Updates on Norwich XIFAXAN Litigation and New FDA Submission XIFAXAN Bausch Health Patent Litigation FDA Submission Norwich Pharmaceuticals
BRIEF published on 05/14/2024 at 22:20, 1 year 10 months ago Sonnet BioTherapeutics Announces Fiscal Year 2024 Q2 Results and Business Updates Financial Results Clinical Trials Oncology Biopharmaceuticals Sonnet BioTherapeutics
BRIEF published on 05/14/2024 at 22:20, 1 year 10 months ago NANOBIOTIX Launches Phase 2 Lung Cancer Treatment Study with FDA Approval FDA Phase 2 Study NANOBIOTIX NBTXR3 Lung Cancer
BRIEF published on 05/14/2024 at 22:15, 1 year 10 months ago GENFIT Announces Q1 2024 Financials and Projects Cash Runway into Late 2025 Cash Position Clinical Trials Revenue Decline Biopharmaceutical Industry GENFIT Financial Results
BRIEF published on 05/14/2024 at 22:10, 1 year 10 months ago Protagonist Therapeutics to Present New Rusfertide Study Data at EHA Congress 2024 Clinical Study Protagonist Therapeutics Rusfertide Polycythemia Vera EHA Congress 2024
Published on 04/08/2026 at 22:05, 1 hour 21 minutes ago GameSquare Achieves First Positive Adjusted EBITDA Quarter in Fourth Quarter, Marking Inflection to Operating Profitability
Published on 04/08/2026 at 18:45, 4 hours 41 minutes ago Nano One to Receive Additional C$4.3M from the Government of Canada to Advance Battery Material Production for Energy Security & Defence
Published on 04/08/2026 at 16:08, 7 hours 18 minutes ago Super Copper Announces Investor Relations Agreement
Published on 04/08/2026 at 14:30, 8 hours 56 minutes ago Goldcliff Confirms Free Gold at Kettle Valley North Cliff Zone, Assays up to 2.70 g/t Au and 29.2 g/t Ag
Published on 04/08/2026 at 21:03, 2 hours 22 minutes ago EQS-Adhoc: Elmos Semiconductor SE: Cancellation of 540,000 treasury shares (approx. 3.05% of the share capital)
Published on 04/08/2026 at 18:10, 5 hours 16 minutes ago PolyPeptide announces results of the annual General Meeting 2026
Published on 04/08/2026 at 18:00, 5 hours 25 minutes ago The General Meeting of Shareholders of Zug Estates Holding Ltd approves all proposals by the Board of Directors
Published on 04/08/2026 at 18:02, 5 hours 24 minutes ago Publication of the 2025 Universal Registration Document
Published on 04/08/2026 at 17:45, 5 hours 41 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 04/08/2026 at 12:58, 10 hours 27 minutes ago EURAZEO IS ASSIGNED A BBB CREDIT RATING (STABLE OUTLOOK) BY S&P AND A BBB CREDIT RATING (STABLE OUTLOOK) BY FITCH
Published on 04/08/2026 at 11:00, 12 hours 26 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 04/08/2026 at 10:17, 13 hours 9 minutes ago BBB LONG-TERM CREDIT RATING WITH A STABLE OUTLOOK EXPECTED FOR EURAZEO FROM BOTH S&P AND FITCH
